New imaging study tracks sugar to tell cancer from inflammation
NCT ID NCT05625217
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study used a total-body PET scanner to track how a radioactive sugar (FDG) behaves in head and neck cancer and inflammation right after injection and many hours later. Seven adults with stage II-IVa oral cancer who were scheduled for radiotherapy took part. The goal was to see if delayed imaging could help tell cancer apart from radiotherapy-related inflammation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better distinguish between cancer and inflammation after radiotherapy, improving treatment monitoring.
What could go wrong
This is a very small, early-stage imaging study with only 7 participants. It is not designed to test a treatment, so direct patient benefits are uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UC Davis EXPLORER Molecular Imaging Center
Sacramento, California, 95816, United States